| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.815 | 0.009 | 0.815 | Caspase 9 stimulant | 0.787 0.013 CID_154699720 | ||
| 0.625 | 0.007 | 0.625 | DNA damaging | 0.625 0.007 CID_154699720 | ||
| 0.607 | 0.014 | 0.607 | 5 Hydroxytryptamine release stimulant | 0.504 0.027 CID_154699720 | ||
| 0.588 | 0.052 | 0.654 | Apoptosis agonist | 0.654 0.038 CID_154699720 | CID_154699720 | |
| 0.547 | 0.014 | 0.547 | Caspase 3 stimulant | 0.48 0.023 CID_154699720 | ||
| 0.529 | 0.013 | 0.529 | MAP kinase kinase 6 inhibitor | 0.346 0.095 CID_154699720 | ||
| 0.515 | 0.006 | 0.515 | Topoisomerase II inhibitor | 0.494 0.007 CID_154699720 | ||
| 0.503 | 0.014 | 0.503 | Amyloid beta aggregation inhibitor | 0.351 0.034 CID_154699720 | ||
| 0.493 | 0.008 | 0.493 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.254 0.102 CID_154699720 | ||
| 0.488 | 0.008 | 0.488 | Tubulin antagonist | 0.192 0.039 CID_154699720 | ||
| 0.486 | 0.016 | 0.486 | Hypoxia-inducible factor 1 alpha inhibitor | 0.453 0.02 CID_154699720 | ||
| 0.464 | 0.005 | 0.464 | Butyrylcholinesterase inhibitor | 0.145 0.036 CID_154699720 | ||
| 0.459 | 0.005 | 0.459 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.303 0.024 CID_154699720 | ||
| 0.427 | 0.004 | 0.427 | Dopamine D1 antagonist | |||
| 0.426 | 0.005 | 0.426 | Topoisomerase I inhibitor | 0.421 0.005 CID_154699720 | ||
| 0.428 | 0.008 | 0.428 | Cholinergic | 0.181 0.056 CID_154699720 | ||
| 0.418 | 0.006 | 0.418 | Acetylcholinesterase inhibitor | 0.197 0.034 CID_154699720 | ||
| 0.405 | 0.005 | 0.426 | Neurotrophic factor enhancer | 0.426 0.005 CID_154699720 | CID_154699720 | |
| 0.412 | 0.021 | 0.412 | Antimitotic | 0.24 0.063 CID_154699720 | ||
| 0.38 | 0.008 | 0.38 | DNA intercalator | 0.339 0.01 CID_154699720 | ||
| 0.423 | 0.059 | 0.743 | Transcription factor NF kappa B inhibitor | 0.743 0.017 CID_154699720 | CID_154699720 | |
| 0.369 | 0.005 | 0.369 | Alpha 2 adrenoreceptor antagonist | |||
| 0.439 | 0.084 | 0.439 | MAP kinase 1 inhibitor | |||
| 0.379 | 0.029 | 0.379 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.381 | 0.032 | 0.445 | Antiamyloidogenic | 0.445 0.022 CID_154699720 | CID_154699720 | |
| 0.395 | 0.057 | 0.406 | Vasodilator, peripheral | 0.406 0.053 CID_154699720 | CID_154699720 | |
| 0.361 | 0.034 | 0.361 | Dyrk kinase inhibitor | |||
| 0.332 | 0.031 | 0.535 | Cyclic AMP phosphodiesterase inhibitor | 0.535 0.005 CID_154699720 | CID_154699720 | |
| 0.351 | 0.055 | 0.521 | Vasodilator, coronary | 0.521 0.013 CID_154699720 | CID_154699720 | |
| 0.301 | 0.009 | 0.301 | Alpha 2b adrenoreceptor antagonist | |||
| 0.302 | 0.011 | 0.302 | Dopamine antagonist | |||
| 0.377 | 0.087 | 0.515 | Histamine release inhibitor | 0.515 0.024 CID_154699720 | CID_154699720 | |
| 0.333 | 0.043 | 0.498 | Free radical scavenger | 0.498 0.016 CID_154699720 | CID_154699720 | |
| 0.296 | 0.01 | 0.296 | Dopamine D2 antagonist | |||
| 0.336 | 0.057 | 0.464 | Spasmolytic | 0.464 0.028 CID_154699720 | CID_154699720 | |
| 0.322 | 0.046 | 0.541 | Tumour necrosis factor alpha release inhibitor | 0.541 0.011 CID_154699720 | CID_154699720 | |
| 0.283 | 0.017 | 0.283 | Alpha adrenoreceptor antagonist | |||
| 0.308 | 0.059 | 0.534 | Antioxidant | 0.534 0.017 CID_154699720 | CID_154699720 | |
| 0.261 | 0.015 | 0.261 | CDC-like kinase 1 inhibitor | 0.115 0.1 CID_154699720 | ||
| 0.283 | 0.042 | 0.283 | Sigma receptor agonist | |||
| 0.246 | 0.005 | 0.246 | Alpha tubulin antagonist | 0.055 0.035 CID_154699720 | ||
| 0.25 | 0.01 | 0.275 | Topoisomerase II alpha inhibitor | 0.275 0.009 CID_154699720 | CID_154699720 | |
| 0.276 | 0.043 | 0.276 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.271 | 0.038 | 0.449 | Hepatoprotectant | 0.449 0.01 CID_154699720 | CID_154699720 | |
| 0.238 | 0.005 | 0.238 | Antineoplastic alkaloid | 0.173 0.021 CID_154699720 | ||
| 0.232 | 0.007 | 0.232 | MAP kinase kinase 4 inhibitor | 0.165 0.038 CID_154699720 | ||
| 0.252 | 0.027 | 0.559 | Amylase inhibitor | 0.559 0.004 CID_154699720 | CID_154699720 | |
| 0.233 | 0.011 | 0.571 | Cyclooxygenase 3 inhibitor | 0.571 0.003 CID_154699720 | CID_154699720 | |
| 0.232 | 0.012 | 0.232 | Alpha 2c adrenoreceptor antagonist | |||
| 0.241 | 0.023 | 0.241 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.224 | 0.009 | 0.224 | Dopamine D3 antagonist | |||
| 0.237 | 0.025 | 0.237 | Heat shock protein 90 antagonist | |||
| 0.267 | 0.057 | 0.267 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.234 | 0.029 | 0.234 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.208 | 0.005 | 0.208 | Potassium channel (Ca-activated) blocker | 0.072 0.025 CID_154699720 | ||
| 0.209 | 0.006 | 0.209 | CDC-like kinase 3 inhibitor | 0.129 0.033 CID_154699720 | ||
| 0.258 | 0.062 | 0.442 | DNA synthesis inhibitor | 0.442 0.018 CID_154699720 | CID_154699720 | |
| 0.241 | 0.048 | 0.241 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.248 | 0.056 | 0.248 | Clk dual-specificity kinase inhibitor | |||
| 0.224 | 0.032 | 0.224 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.195 | 0.005 | 0.195 | Phosphodiesterase XI inhibitor | 0.081 0.057 CID_154699720 | ||
| 0.195 | 0.005 | 0.195 | Phosphodiesterase 11A inhibitor | 0.081 0.057 CID_154699720 | ||
| 0.251 | 0.061 | 0.251 | Pyruvate kinase inhibitor | |||
| 0.235 | 0.049 | 0.235 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.196 | 0.012 | 0.513 | AMP-activated protein kinase stimulant | 0.513 0.003 CID_154699720 | CID_154699720 | |
| 0.212 | 0.028 | 0.332 | ATPase inhibitor | 0.332 0.005 CID_154699720 | CID_154699720 | |
| 0.214 | 0.03 | 0.214 | NADPH oxidase inhibitor | 0.165 0.046 CID_154699720 | ||
| 0.201 | 0.019 | 0.201 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.185 | 0.004 | 0.185 | Topoisomerase II beta inhibitor | 0.118 0.007 CID_154699720 | ||
| 0.189 | 0.008 | 0.189 | Beta tubulin antagonist | |||
| 0.243 | 0.064 | 0.243 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.241 | 0.062 | 0.241 | EphB2 antagonist | |||
| 0.19 | 0.015 | 0.19 | Alpha 2a adrenoreceptor antagonist | |||
| 0.271 | 0.097 | 0.271 | 12-Lipoxygenase inhibitor | |||
| 0.186 | 0.015 | 0.186 | Breast cancer-resistant protein inhibitor | |||
| 0.233 | 0.065 | 0.239 | Psychostimulant | 0.239 0.063 CID_154699720 | CID_154699720 | |
| 0.22 | 0.055 | 0.22 | Insulin sensitizer | 0.185 0.09 CID_154699720 | ||
| 0.203 | 0.041 | 0.203 | Acetylcholine M1 receptor antagonist | |||
| 0.239 | 0.083 | 0.564 | Hypoglycemic | 0.564 0.01 CID_154699720 | CID_154699720 | |
| 0.162 | 0.012 | 0.162 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.117 0.027 CID_154699720 | ||
| 0.186 | 0.037 | 0.186 | 5 Hydroxytryptamine antagonist | |||
| 0.173 | 0.025 | 0.173 | Alpha 1 adrenoreceptor antagonist | |||
| 0.232 | 0.088 | 0.232 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.227 | 0.086 | 0.227 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.205 | 0.065 | 0.205 | CDC-like kinase 4 inhibitor | |||
| 0.285 | 0.147 | 0.648 | Antibacterial | 0.648 0.013 CID_154699720 | CID_154699720 | |
| 0.156 | 0.019 | 0.156 | Protein kinase C zeta inhibitor | |||
| 0.258 | 0.122 | 0.258 | Prostaglandin dehydrogenase inhibitor | |||
| 0.183 | 0.049 | 0.256 | Lipid peroxidase inhibitor | 0.256 0.026 CID_154699720 | CID_154699720 | |
| 0.192 | 0.069 | 0.195 | P-glycoprotein inhibitor | 0.195 0.068 CID_154699720 | CID_154699720 | |
| 0.192 | 0.07 | 0.364 | Nitric oxide antagonist | 0.364 0.03 CID_154699720 | CID_154699720 | |
| 0.271 | 0.149 | 0.271 | 15-Lipoxygenase inhibitor | |||
| 0.205 | 0.087 | 0.205 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.156 | 0.038 | 0.156 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.189 | 0.072 | 0.189 | CDC-like kinase 2 inhibitor | |||
| 0.167 | 0.058 | 0.267 | Insulin secretagoues | 0.267 0.017 CID_154699720 | CID_154699720 | |
| 0.138 | 0.029 | 0.138 | DOPA decarboxylase inhibitor | |||
| 0.124 | 0.016 | 0.124 | mTOR complex 2 inhibitor | |||
| 0.144 | 0.037 | 0.241 | DNA repair enzyme inhibitor | 0.241 0.005 CID_154699720 | CID_154699720 | |
| 0.118 | 0.013 | 0.118 | Protein kinase C eta inhibitor | 0.079 0.024 CID_154699720 | ||
| 0.122 | 0.018 | 0.122 | Phosphodiesterase V inhibitor | |||
| 0.16 | 0.06 | 0.16 | Activin receptor-like kinase 2 inhibitor | |||
| 0.188 | 0.088 | 0.188 | Histone acetyltransferase inhibitor | |||
| 0.134 | 0.034 | 0.134 | Protein kinase C mu inhibitor | |||
| 0.158 | 0.061 | 0.158 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.136 | 0.041 | 0.136 | Protein kinase C gamma inhibitor | |||
| 0.144 | 0.049 | 0.282 | Alkylator | 0.282 0.014 CID_154699720 | CID_154699720 | |
| 0.123 | 0.029 | 0.123 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.217 | 0.124 | 0.217 | Lipoxygenase inhibitor | |||
| 0.138 | 0.047 | 0.138 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.16 | 0.069 | 0.217 | Melanin inhibitor | 0.217 0.035 CID_154699720 | CID_154699720 | |
| 0.11 | 0.022 | 0.11 | Phosphodiesterase 5A inhibitor | |||
| 0.129 | 0.042 | 0.129 | Activin receptor-like kinase 4 inhibitor | |||
| 0.126 | 0.043 | 0.126 | Antiadrenergic | |||
| 0.096 | 0.013 | 0.096 | Protein kinase C epsilon inhibitor | |||
| 0.11 | 0.028 | 0.128 | ATPase (Vacuolar H+) inhibitor | 0.128 0.015 CID_154699720 | CID_154699720 | |
| 0.158 | 0.078 | 0.158 | Heat shock protein 90 alpha antagonist | |||
| 0.261 | 0.181 | 0.519 | Alpha-glucosidase inhibitor | 0.519 0.075 CID_154699720 | CID_154699720 | |
| 0.122 | 0.043 | 0.122 | Adrenaline antagonist | |||
| 0.089 | 0.01 | 0.089 | Dopamine D5 antagonist | |||
| 0.082 | 0.007 | 0.082 | Factor III inhibitor | 0.081 0.007 CID_154699720 | ||
| 0.139 | 0.063 | 0.139 | Cyclooxygenase 1 inhibitor | 0.101 0.099 CID_154699720 | ||
| 0.108 | 0.033 | 0.108 | Alpha 1a adrenoreceptor antagonist | |||
| 0.132 | 0.057 | 0.132 | Acetylcholine muscarinic antagonist | |||
| 0.161 | 0.087 | 0.161 | Tumour necrosis factor antagonist | |||
| 0.102 | 0.027 | 0.102 | Acetylcholine M4 receptor antagonist | |||
| 0.104 | 0.03 | 0.104 | Histidine decarboxylase inhibitor | |||
| 0.105 | 0.032 | 0.105 | Macrophage migration inhibitory factor inhibitor | |||
| 0.08 | 0.009 | 0.08 | Ryanodine receptor antagonist | |||
| 0.074 | 0.004 | 0.074 | Protein kinase C beta II inhibitor | 0.049 0.006 CID_154699720 | ||
| 0.186 | 0.116 | 0.314 | Vasodilator | 0.314 0.044 CID_154699720 | CID_154699720 | |
| 0.122 | 0.051 | 0.122 | MAO A inhibitor | |||
| 0.095 | 0.025 | 0.095 | Protein kinase C alpha inhibitor | |||
| 0.098 | 0.029 | 0.098 | Lipase inhibitor | 0.066 0.059 CID_154699720 | ||
| 0.13 | 0.062 | 0.13 | Acetylcholine antagonist | |||
| 0.094 | 0.028 | 0.094 | HIV-1 integrase inhibitor | |||
| 0.083 | 0.019 | 0.083 | Heat shock protein 90 beta antagonist | |||
| 0.13 | 0.065 | 0.13 | Cholinergic antagonist | |||
| 0.089 | 0.026 | 0.089 | MAP kinase kinase 7 inhibitor | |||
| 0.105 | 0.043 | 0.151 | Phosphodiesterase 6D inhibitor | 0.151 0.009 CID_154699720 | CID_154699720 | |
| 0.219 | 0.157 | 0.383 | Apoptosis antagonist | 0.383 0.043 CID_154699720 | CID_154699720 | |
| 0.084 | 0.023 | 0.084 | Glutamate (mGluR7) antagonist | |||
| 0.069 | 0.008 | 0.069 | Endothelin receptor antagonist | |||
| 0.132 | 0.072 | 0.132 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.089 | 0.032 | 0.089 | Dopamine agonist | |||
| 0.162 | 0.107 | 0.162 | I kappa B kinase epsilon inhibitor | |||
| 0.09 | 0.036 | 0.09 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.086 | 0.032 | 0.098 | Phosphodiesterase VI inhibitor | 0.098 0.021 CID_154699720 | CID_154699720 | |
| 0.123 | 0.073 | 0.123 | MAO inhibitor | |||
| 0.114 | 0.065 | 0.114 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.069 | 0.021 | 0.069 | Bcl-xL inhibitor | |||
| 0.05 | 0.004 | 0.05 | Protein kinase C beta I inhibitor | 0.045 0.005 CID_154699720 | ||
| 0.077 | 0.032 | 0.077 | Acetylcholine M2 receptor antagonist | |||
| 0.077 | 0.035 | 0.077 | Protein kinase C beta inhibitor | |||
| 0.134 | 0.092 | 0.134 | Adenylate cyclase stimulant | |||
| 0.107 | 0.066 | 0.121 | Multidrug resistance-associated protein 1 inhibitor | 0.121 0.047 CID_154699720 | CID_154699720 | |
| 0.042 | 0.006 | 0.042 | Endothelin B receptor antagonist | |||
| 0.079 | 0.045 | 0.079 | Glutamate decarboxylase inhibitor | |||
| 0.123 | 0.089 | 0.24 | Protein kinase stimulant | 0.24 0.029 CID_154699720 | CID_154699720 | |
| 0.061 | 0.029 | 0.061 | 5 Hydroxytryptamine 7 agonist | |||
| 0.129 | 0.097 | 0.129 | MAP3K9 inhibitor | |||
| 0.159 | 0.129 | 0.159 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.037 | 0.008 | 0.037 | Endothelin A receptor antagonist | |||
| 0.097 | 0.07 | 0.097 | Estrogen receptor beta antagonist | |||
| 0.055 | 0.028 | 0.055 | AMPA receptor antagonist | |||
| 0.144 | 0.118 | 0.144 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.076 | 0.052 | 0.076 | GABA B receptor agonist | |||
| 0.062 | 0.041 | 0.087 | Neuraminidase inhibitor | 0.087 0.021 CID_154699720 | CID_154699720 | |
| 0.127 | 0.108 | 0.127 | Pregnane X receptor agonist | |||
| 0.105 | 0.086 | 0.105 | Estrogen antagonist | |||
| 0.047 | 0.029 | 0.047 | Dopamine D2 agonist | |||
| 0.17 | 0.152 | 0.17 | RNA-directed DNA polymerase inhibitor | |||
| 0.06 | 0.044 | 0.06 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.079 | 0.064 | 0.079 | Inducible nitric-oxide synthase inhibitor | |||
| 0.068 | 0.054 | 0.068 | Alpha 1b adrenoreceptor antagonist | |||
| 0.109 | 0.096 | 0.109 | Bone formation stimulant | |||
| 0.051 | 0.04 | 0.051 | 5 Hydroxytryptamine 1B agonist | |||
| 0.025 | 0.013 | 0.025 | Dopamine D1 agonist | 0.022 0.017 CID_154699720 | ||
| 0.083 | 0.073 | 0.083 | Protein kinase C delta inhibitor | |||
| 0.102 | 0.092 | 0.102 | Interleukin 8 antagonist | |||
| 0.057 | 0.047 | 0.057 | Alpha 2 adrenoreceptor agonist | |||
| 0.059 | 0.049 | 0.059 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.033 | 0.023 | 0.033 | Catechol O-methyltransferase inhibitor | |||
| 0.043 | 0.034 | 0.043 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.054 | 0.046 | 0.054 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.044 | 0.039 | 0.044 | Phosphodiesterase 6C inhibitor | |||
| 0.129 | 0.126 | 0.172 | Interleukin 6 antagonist | 0.172 0.062 CID_154699720 | CID_154699720 | |
| 0.069 | 0.068 | 0.069 | Keratolytic | |||
| 0.239 | 0.244 | 0.341 | 5 Hydroxytryptamine release inhibitor | 0.341 0.123 CID_154699720 | CID_154699720 | |
| 0.095 | 0.101 | 0.116 | Microtubule formation inhibitor | 0.116 0.065 CID_154699720 | CID_154699720 | |
| 0.121 | 0.148 | 0.14 | Anesthetic general | 0.14 0.125 CID_154699720 | CID_154699720 | |
| 0.122 | 0.166 | 0.321 | Non-steroidal antiinflammatory agent | 0.321 0.024 CID_154699720 | CID_154699720 | |
| 0.161 | 0.223 | 0.212 | Angiogenesis inhibitor | 0.212 0.156 CID_154699720 | CID_154699720 | |
| 0.054 | 0.119 | 0.106 | Glycine receptor antagonist | 0.106 0.027 CID_154699720 | CID_154699720 | |
| 0.062 | 0.13 | 0.09 | Uric acid excretion stimulant | 0.09 0.065 CID_154699720 | CID_154699720 | |
| 0.067 | 0.139 | 0.097 | Xanthine oxidase inhibitor | 0.097 0.062 CID_154699720 | CID_154699720 | |
| 0.198 | 0.278 | 0.646 | Cyclophilin D inhibitor | 0.646 0.02 CID_154699720 | CID_154699720 | |
| 0.076 | 0.168 | 0.203 | Cell adhesion inhibitor | 0.203 0.024 CID_154699720 | CID_154699720 | |
| 0.031 | 0.124 | 0.137 | Antineoplastic antibiotic | 0.137 0.034 CID_154699720 | CID_154699720 | |
| 0.009 | 0.115 | 0.046 | Sodium/glucose cotransporter 2 inhibitor | 0.046 0.007 CID_154699720 | CID_154699720 | |
| 0.211 | 0.318 | 0.643 | Antiinflammatory | 0.643 0.042 CID_154699720 | CID_154699720 | |
| 0.024 | 0.15 | 0.062 | Alpha-mannosidase inhibitor | 0.062 0.024 CID_154699720 | CID_154699720 | |
| 0.025 | 0.156 | 0.061 | Nitric oxide donor | 0.061 0.047 CID_154699720 | CID_154699720 | |
| 0.054 | 0.194 | 0.117 | Transcription factor NF kappa B stimulant | 0.117 0.027 CID_154699720 | CID_154699720 | |
| 0.045 | 0.187 | 0.176 | Expectorant | 0.176 0.026 CID_154699720 | CID_154699720 | |
| 0.027 | 0.173 | 0.061 | Neuraminidase (influenza) inhibitor | 0.061 0.052 CID_154699720 | CID_154699720 | |
| 0.026 | 0.173 | 0.063 | Glucose-6-phosphate translocase inhibitor | 0.063 0.021 CID_154699720 | CID_154699720 | |
| 0.08 | 0.232 | 0.174 | NOS3 expression enhancer | 0.174 0.053 CID_154699720 | CID_154699720 | |
| 0.015 | 0.178 | 0.049 | Mannosidase inhibitor | 0.049 0.026 CID_154699720 | CID_154699720 | |
| 0.009 | 0.185 | 0.03 | Sodium/glucose cotransporter inhibitor | 0.03 0.011 CID_154699720 | CID_154699720 | |
| 0.117 | 0.31 | 0.519 | Antithrombotic | 0.519 0.027 CID_154699720 | CID_154699720 | |
| 0.118 | 0.316 | 0.325 | Peptidyltransferase inhibitor | 0.325 0.017 CID_154699720 | CID_154699720 | |
| 0.071 | 0.292 | 0.231 | Hemostatic | 0.231 0.024 CID_154699720 | CID_154699720 | |
| 0.068 | 0.29 | 0.296 | Platelet adhesion inhibitor | 0.296 0.035 CID_154699720 | CID_154699720 | |
| 0.041 | 0.272 | 0.232 | Thrombolytic | 0.232 0.039 CID_154699720 | CID_154699720 | |
| 0.015 | 0.254 | 0.076 | Protein 50S ribosomal subunit inhibitor | 0.076 0.021 CID_154699720 | CID_154699720 | |
| 0.038 | 0.282 | 0.104 | Beta glucuronidase inhibitor | 0.104 0.063 CID_154699720 | CID_154699720 | |
| 0.02 | 0.284 | 0.071 | Heparanase inhibitor | 0.071 0.011 CID_154699720 | CID_154699720 | |
| 0.008 | 0.272 | 0.024 | Protein 30S ribosomal subunit inhibitor | 0.024 0.016 CID_154699720 | CID_154699720 | |
| 0.051 | 0.344 | 0.179 | Hypolipemic | 0.179 0.111 CID_154699720 | CID_154699720 | |
| 0.046 | 0.388 | 0.208 | Platelet antagonist | 0.208 0.096 CID_154699720 | CID_154699720 | |
| 0.036 | 0.379 | 0.117 | Toll-Like receptor 4 antagonist | 0.117 0.047 CID_154699720 | CID_154699720 | |
| 0.086 | 0.459 | 0.125 | CC chemokine 6 receptor antagonist | 0.125 0.089 CID_154699720 | CID_154699720 | |
| 0.03 | 0.443 | 0.441 | Angiogenesis stimulant | 0.441 0.016 CID_154699720 | CID_154699720 | |
| 0.051 | 0.491 | 0.355 | Immunosuppressant | 0.355 0.084 CID_154699720 | CID_154699720 | |
| 0.029 | 0.472 | 0.235 | Immunostimulant | 0.235 0.103 CID_154699720 | CID_154699720 | |
| 0.012 | 0.49 | 0.055 | Antibiotic Aminoglycoside-like | 0.055 0.011 CID_154699720 | CID_154699720 | |
| 0.007 | 0.498 | 0.227 | Selectin antagonist | 0.227 0.009 CID_154699720 | CID_154699720 | |
| 0.067 | 0.687 | 0.305 | Interleukin 2 agonist | 0.305 0.07 CID_154699720 | CID_154699720 | |
| 0.012 | 0.651 | 0.127 | Anticoagulant | 0.127 0.104 CID_154699720 | CID_154699720 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |